A Leading Location
The German capital region provides outstanding potential for development and ideal conditions for the biotechnology and pharmaceuticals industry. Its major strengths are a unique research landscape and a close network of the players along the entire value-added chain. Its many technology parks and networks in various fields of modern biotechnology provide an excellent infrastructure and form the technological backbone of the biotechnology and pharmaceuticals industry in Berlin and Brandenburg.
Are you planning on developing your company’s presence in the German capital? A good choice! We will help you implement your decision to locate or expand your company in Berlin-Brandenburg.
Berlin, Germany, and Toronto, Canada, MAY 24, 2016: SCIENION AG, a developer of a revolutionary new ultra-low volume liquid handling technology, is pleased to announce that it has entered into a strategic, joint development...
Alliance for Regenerative Medicine Releases Q3 2015 Data Report, Highlighting Sector Trends and Metrics
WASHINGTON, D.C., November 2, 2015 – The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine and advanced therapies community, today announced the release of its...
"Inside BCRT" is our new annual magazine in a somewhat different format. We want to give you an insight into our research center and information on some of the many projects. In spring this year we started our third funding...
Entrance Markgrafenstraße 38
Nils Ericsons Plan 4
The largest Nordic partnering conference for the global Life Science industry / HealthCapital Berlin-Brandenburg is acting as conference supporter / Early Bird rates apply!